Literature DB >> 11723200

Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.

C Holmes1, H Smith, R Ganderton, M Arranz, D Collier, J Powell, S Lovestone.   

Abstract

This study investigated possible associations between selected polymorphisms in the dopamine receptor genes DRD1 and DRD3 with the presence of psychotic phenomena or aggressive behaviour in a community based cohort of 134 patients with late onset Alzheimer's disease. An association was found between the presence of psychotic symptoms and aggressive behaviour and the DRD1 polymorphism and between the presence of psychosis, but not aggression, and the DRD3 polymorphism. Specifically, carriers of the DRD1 B2 allele were more likely to be aggressive or experience hallucinations whereas homozygous carriers of the DRD3 1 allele were more likely to experience delusions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723200      PMCID: PMC1737623          DOI: 10.1136/jnnp.71.6.777

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Behavioral disturbance in dementia.

Authors:  Abhilash K Desai; Lori Schwartz; George T Grossberg
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

Review 2.  Genetics of psychosis of Alzheimer disease.

Authors:  Chintan Shah; Mary Ann A DeMichele-Sweet; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-01-12       Impact factor: 3.568

3.  Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation.

Authors:  Steven P Cercy; Martin J Sadowski; Thomas Wisniewski
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

Review 4.  Psychiatric and behavioral symptoms in Alzheimer's disease and other dementias: etiology and management.

Authors:  Dag Aarsland; Sally Sharp; Clive Ballard
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

5.  Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease.

Authors:  Jing Tian; Lan Guo; Shaomei Sui; Christopher Driskill; Aarron Phensy; Qi Wang; Esha Gauba; Jeffrey M Zigman; Russell H Swerdlow; Sven Kroener; Heng Du
Journal:  Sci Transl Med       Date:  2019-08-14       Impact factor: 17.956

Review 6.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Neurobiology of delusions in Alzheimer's disease.

Authors:  Zahinoor Ismail; Minh-Quan Nguyen; Corinne E Fischer; Tom A Schweizer; Benoit H Mulsant; David Mamo
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

8.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

9.  Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

Authors:  M Ferrari; C Comi; F Marino; L Magistrelli; F De Marchi; R Cantello; G Riboldazzi; G Bono; M Cosentino
Journal:  Eur J Clin Pharmacol       Date:  2016-08-06       Impact factor: 2.953

10.  Functional coupling between heterologously expressed dopamine D(2) receptors and KCNQ channels.

Authors:  Trine Ljungstrom; Morten Grunnet; Bo Skaaning Jensen; Søren-Peter Olesen
Journal:  Pflugers Arch       Date:  2003-06-21       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.